Overcoming MET-Dependent Resistance to Selective RET Inhibition in Patients with RET Fusion-Positive Lung Cancer by Combining Selpercatinib with Crizotinib

Added 255 days ago (04.01.2021)
Authors: Rosen, E. Y., Johnson, M. L., Clifford, S. E., Somwar, R., Kherani, J. F., Son, J., Bertram, A. A., Davare, M. A., Gladstone, E., Ivanova, E. V., Henry, D. N., Kelley, E. M., Lin, M., Milan, M. S. D., Nair, B. C., Olek, E. A., Scanlon, J. E., Vojnic, M., Ebata, K., Hechtman, J. F., Li, B. T., Sholl, L. M., Taylor, B. S., Ladanyi, M., Jänne, P. A., Rothenberg, S. M., Drilon, A., Oxnard, G. R.
Read article